Not Tagged
Castle Biosciences
[]
$cstl late-breaking data presented at the 2023 aad annual meeting demonstrates improved accuracy of decisiondx -scc in predicting metastatic risk over traditional staging systems in independent, multi-center cohort s 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i